¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Gibbs phenomenon"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® rebound phenomenon ÇÑ±Û ¹Ý¹ßÇö»ó, ¹Ýµ¿Çö»ó
¼³¸í   
  ¼Ò³ú ±â´ÉÀå¾Ö¿¡¼­ »çÁöÀÇ ´ëÇ×±ÙÀ° »çÀÌÀÇ ÇùÁ¶¼º »ó½ÇÀǠ¡Èķμ­, È¯ÀÚ¿¡°Ô ¾çÆÈÀ» ¼öÆòÀ¸·Î »¸°Ô ÇÏ°í ±× ÆÈÀ» °­ÇϰԠġ¸é Á¤»óÀΠ°æ¿ì´Â °ð ¿ø»óÀ¸·Î ¿Ã¸®´Âµ¥ ºñÇÏ¿© È¯ÀÚ¿¡ À־´Â ¿øÀ§Ä¡·Î µ¹¾Æ¿À´Â µ¥ ¸î ¹øÀ̳ª ¶³°Ô µÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aqueous-influx phenomenon
    ¹æ¼öÀ¯ÀÔÇö»ó
  • adoption phenomenon
    ä¿ëÇö»ó
  • clasp-knife phenomenon
    Á¢´ÂÄ®Çö»ó
  • closing-in phenomenon
    Á¾°áÇö»ó
  • critical phenomenon
    ÀÓ°èÇö»ó
  • crowding phenomenon
    ¹ÐÁýÇö»ó
  • cytopathogenic phenomenon
    ¼¼Æ÷º¯¼ºÇö»ó
  • centralization phenomenon
    Áß½ÉÈ­Çö»ó
  • duplication phenomenon
    º¹Á¦Çö»ó
  • delay phenomenon
    Áö¿¬Çö»ó
  • dawn phenomenon
    »õº®Çö»ó, ¿©¸íÇö»ó
  • discontinuity phenomenon
    ºÒ¿¬¼ÓÇö»ó
  • dissociative phenomenon
    ÇØ¸®Çö»ó
  • doll¡¯s head phenomenon
    ÀÎÇü¸Ó¸®Çö»ó
  • entoptic phenomenon
    ³»½ÃÇö»ó
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phenomenon
    Çö»ó
  • phantom phenomenon
    ÇêÇö»ó, ȯ»óÇö»ó
  • rebound phenomenon
    ¹Ýµ¿Çö»ó
  • recruitment phenomenon
    Á¡ÁõÇö»ó, ´©°¡Çö»ó, º¸ÃæÇö»ó
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adoption phenomenon
    ä¿ëÇö»ó
  • aqueous-influx phenomenon
    ¹æ¼öÀ¯ÀÔÇö»ó
  • clasp-knife phenomenon
    Á¢´ÂÄ®Çö»ó
  • closing-in phenomenon
    Á¾°áÇö»ó
  • critical phenomenon
    ÀÓ°èÇö»ó
  • crowding phenomenon
    ¹ÐÁýÇö»ó
  • cytopathogenic phenomenon
    ¼¼Æ÷º¯¼ºÇö»ó
  • delay phenomenon
    Áö¿¬Çö»ó
  • discontinuity phenomenon
    ºÒ¿¬¼ÓÇö»ó
  • dissociative phenomenon
    ÇØ¸®Çö»ó
  • doll¡¯s head phenomenon
    ÀÎÇü¸Ó¸®Çö»ó
  • down phenomenon
    »õº®Çö»ó, ¿©¸íÇö»ó
  • duplication phenomenon
    º¹Á¦Çö»ó
  • entoptic phenomenon
    ³»½ÃÇö»ó
  • entry phenomenon
    ÁøÀÔÇö»ó
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Gibbs phenomenon
    ±é½º Çö»ó
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Gibbs artefact
    ±é½º Àΰø¹°
  • Gibbs effect
    ±é½º È¿°ú
  • Gibbs-Donnan equilibrium
    ±é½º-µ·³­ÆòÇü(øÁû¬).
  • Arthus phenomenon
    ¾Æ¸£Åõ½º Çö»ó(~ úÞßÚ)
  • Arthuss phenomenon
    ¾Æ¸£Åõ½ºÇö»ó
  • Bells phenomenon
    º§Çö»ó
  • CRST(Calcinosis, Raynauds phenomenon, Sclerodactyly, Telangiectasia) syndrome
    CRST ÁõÈıº.
  • Chameleon phenomenon
    Ä«¸á·¹¿ÂÇö»ó.
  • Danysz phenomenon
    Danysz Çö»ó
  • Danyszs phenomenon
    ´Ù´ÏÁî Çö»ó
  • Faraday s phenomenon
    ÆÐ·¯µ¥ÀÌÇö»ó.
  • Fowler phenomenon
    º¸ÃæÇö»ó
  • Gunns pupillary phenomenon
    °Ç¾¾µ¿°øÇö»ó
  • Hirsts phenomenon
    Ç㽺Ʈ Çö»ó
  • Jack-in-the-box phenomenon
    µ¹¿¬½ÃÇö»ó
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lupus erythematosus phenomenon = LE phenomenon
    È«¹Ý¼º ·çǪ½ºÇö»ó(¡­úÞßÚ)
  • anamnestic phenomenon
    ±â¿ÕÇö»ó (¡­úÞßÚ).
  • anamnestic phenomenon
    ¸é¿ª[ÇÐÀû]±â¾ï[Çö»ó]
  • aqueous-influx phenomenon
    ¹æ¼öÀ¯ÀÔÇö»ó
  • arm phenomenon
    ÆÈ Çö»ó.
  • autoscopic phenomenon
    ÀÚ±âȯ¿µÇö»ó
  • blanching phenomenon
    â¹éÇö»ó(óïÛÜúÞßÚ).
  • blue-field entopic phenomenon
    û»ö½Ã¾ß³»½ÃÇö»ó
  • blush-and-blanch phenomenon
    È«Á¶Ã¢¹éÇö»ó(ûõðÍóïÛÜúÞßÚ).
  • break off phenomenon
    ÀÌÅ»°¨°¢Çö»ó(ìÆ÷­ÊïÊÆúÞßÚ)
  • break phenomenon
    ±úÁüÇö»ó, ÆÄ¿­Çö»ó
  • bulbar phenomenon
    ¿¬¼öÇö»ó.
  • cervicolumbar phenomenon
    °æ¿äÇö»ó(Ìòé¦úÞßÚ).
  • clasp knife phenomenon
    Á¢´Â Ä® Çö»ó
  • clasp-knife phenomenon
    Á¢´Â Ä® Çö»ó.
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Sarle's phenomenon
    »ì·¹Çö»ó
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Danysz phenomenon
    ´ë´ÏÁî Çö»ó(úÞßÚ)
  • ectrokinetic phenomenon
    °è¸éµ¿Àü±â Çö»ó(Í£ØüÔÑï³Ñ¨úÞßÚ)
  • plateau phenomenon
    Ç÷¡Åä Çö»ó(úÞßÚ)
  • Gibbs-Donnan equilibrium
    ±é½º-µ·³­ ÆòÇü(øÁû¬)
  • Gibbs-Duhem equation
    ±é½º-µÎÇð ¹æÁ¤½Ä(Û°ïïãÒ)
  • Gibbs free energy
    ±é½º ÀÚÀ¯(í»ë¦)¿¡³ÊÁö
  • Gibbs-Helmholtz equation
    ±é½º-Ç︧ȦÃ÷ ¹æÁ¤½Ä(Û°ïïãÒ)
  • Gibbs phase rule
    ±é½º À§»ó ¹ýÄ¢(êÈßÓÛööÎ)
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Gibbs phenomenon
    ±é½ºÇö»ó
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Gibbs artefact
    ±é½º Àΰø¹°
  • Gibbs effect
    ±é½º È¿°ú
  • entry phenomenon
    ÁøÀÔÇö»ó
  • entry slice phenomenon
    À¯ÀԴܸéÇö»ó
  • flare phenomenon
    Àå°³Çö»ó
  • iceberg phenomenon
    ºù»ê Çö»ó
  • phenomenon
    Çö»ó
  • rebound phenomenon
    ¹Ýµ¿Çö»ó
  • slice entry phenomenon
    ÀýÆíÀÔ±¸Çö»ó
  • sunset phenomenon
    ÀϸôÇö»ó
  • time of flight phenomenon
    À¯Ã¼¼Óµµ°­Á¶Çö»ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CREST Syndrome   1. Calcinosis cutis
  2. Raynaud's phenomenon
  3. Esophageal ...
CRST Syndrome   1. Calcinosis
  2. Raynaud's Phenomenon
  3. Sclerodactyly
...
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
VF   1) Ventricular Fibrillation
    ? Tx of Ventricular Fibrillation ...
B-G Bordet-Gengou [agar, bacillus, phenomenon]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
PRP Primary Raynaud's Phenomenon
RP Raynaud Phenomenon
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • aldosterone escape phenomenon
    ¾Ëµµ½ºÅ×·Ð ¹èÃâ Çö»ó
    ¼¼Æ÷ ¿Ü¾×ÀÌ ¾î´À Á¤µµ Áõ°¡Çϸé aldosteroneÀÇ ºÐºñ°¡ °è¼Ó Áõ°¡ÇÏ´õ¶óµµ ³ªÆ®·ýÀÇ ¹è¼³ÀÌ Áõ°¡ÇÏ´Â Çö»óÀ» ¸»ÇÑ´Ù. ÀÌ Çö»óÀº ¼¼Æ÷ ¿Ü¾×ÀÇ Áõ°¡¿Í ÀϺδ ANH
  • aqueous-influx phenomenon
    ¹æ¼ö À¯ÀÔ Çö»ó
  • arthus phenomenon
    ¾Æ¸£Æ©½º Çö»ó
  • central pain phenomenon
    ÁßÃß¼º µ¿Åë Çö»ó
  • Chiristensen phenomenon
    Å©¸®½ºÅÙ¼¾ Çö»ó
    ÇϾÇÀÇ Àü¹æ¿îµ¿ ½Ã ´ëÇÕÇÏ´Â ±³ÇÕ¸é »çÀÌ¿¡ »ý±â´Â °£°Ý.
  • Christensen's phenomenon
    Å©¸®½ºÅÙ¼¾ Çö»ó
  • Class Switching phenomenon
    ºÐ·ù Àüȯ Çö»ó
    ÇϳªÀÇ B ¼¼Æ÷°¡ ±×¿¡ »óÀÀÇÒ ¼ö Àִ ƯÀÌ Ç׿ø¿¡ Á¢ÇÏ¿´À» ¶§ isoty
  • dawn phenomenon
    »õº® Çö»ó
    Á¦ 1Çü ´ç´¢º´ ȯÀÚÀÇ 75%¿¡¼­, ±×¸®°í ´Ù¼öÀÇ Á¦ 2Çü ´ç´¢º´ ȯÀÚ ¹× Á¤»óÀο¡¼­µµ ÀϾ´Ù. À̰ÍÀº ¿ÀÀü 5-8½Ã »çÀÌ¿¡ Àν¶¸°¿¡ ´ëÇÑ Á¶Á÷ÀÇ °¨¼ö¼ºÀÌ °¨¼ÒÇÏ¿© ÀϾ´Ù. ÃÖ±ÙÀÇ Áõ°Å´Â ÀÌ Çö»óÀÌ ¼ö¸é Áß¿¡ ¼ºÀå È£¸£¸ó ºÐºñÀÇ Áõ°¡¿¡ ÀÇÇÏ¿© À¯¹ßµÇ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. »õº® Çö»óÀÌ ´Üµ¶À» ¹ß»ýÇϸé À̸¥ ¾ÆÄ§¿¡ °æµµÀÇ °íÇ÷´çÁõÀÌ ¿À³ª ¼Ò¸ð±â È¿°ú³ª °¨Åð Çö»óÀÌ µ¿¹ÝµÇ¸é °íÇ÷´çÁõÀº ½ÉÇØÁø´Ù.
  • dolls head phenomenon
    ÀÎÇü ¸Ó¸® Çö»ó, ÀÎÇü µÎ Çö»ó
  • flare phenomenon
    Àå°³ Çö»ó
  • Fowler phenomenon
    º¸Ãæ Çö»ó
  • iceberg phenomenon
    ºù»ê Çö»ó
  • jaw winking phenomenon
    ÅÎ-À®Å© Çö»ó
  • light absorption phenomenon
    ºû Èí¼ö Çö»ó
  • metallic phenomenon
    ±Ý¼Ó¼º Çö»ó
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
Gibbs J. Willard, U.S. Mathematician and physicist, 1839-1903.
See: Gibbs-Donnan equilibrium, Gibbs-Helmholtz equation, Helmholtz-Gibbs theory, Gibbs' theorem, Gibbs free energy, Gibbs energy of activation.
(05 Mar 2000)
gibbs-donnan effect The observation that charged molecules starting on one side of a semipermeable membrane sometimes will not evenly distribute themselves by diffusion on both sides of the membrane. This effect is probably because there are other charged substances already present which cannot move through the membrane themselves and which are creating an electric field that influences the movement of the incoming charged molecules.
(09 Oct 1997)
Gibbs-Donnan equilibrium An equilibrium established between a charged, immobile colloid (such as clay, ion exchange resin or cytoplasm) and a solution of electrolyte.
Characteristics: ions of like charge to the colloid tend to be excluded, ions of opposite charge tend to be attracted, the colloid compartment is electrically polarized relative to the solution in the same direction as the colloid charges (a Donnan potential) and the osmotic pressure is higher in the colloid compartment.
(18 Nov 1997)
Gibbs energy of activation The Gibbs energy that must be added to that already possessed by a molecule or molecules in order to initiate a reaction.
(05 Mar 2000)
gibbs free energy The total amount of energy which is either used up or released during a chemical reaction. Gibbs free energy (delta G) = (delta H) - t (delta s): where (delta H) is the change in enthalpy, calculated by adding up the amount of energy released or used up to break or form chemical bonds during the reaction, t is the temperature at which the reaction took place, and (delta S) is the change in entropy, or amount of disorder, that occurs in the molecules involved during the reaction.
(09 Oct 1997)
Gibbs-Helmholtz equation An equation expressing the relationship in a galvanic cell between the chemical energy transformed and the maximal electromotive force obtainable.
(05 Mar 2000)
Gibbs' theorem Substances that lower the surface tension of the pure dispersion medium tend to collect in its surface, whereas substances that raise the surface tension tend to remain out of the surface film.
(05 Mar 2000)
Helmholtz-Gibbs theory An equation expressing the relationship in a galvanic cell between the chemical energy transformed and the maximal electromotive force obtainable.
(05 Mar 2000)
adhesion phenomenon A phenomenon manifested by the adherence of antigen-antibody-complement complex to "indicator cells" (microorganisms, platelets, leukocytes, or erythrocytes), the reaction being sensitive and specific for the antigen and antibody in the complex.
Synonym: erythrocyte adherence phenomenon, immune adherence phenomenon, red cell adherence phenomenon.
(05 Mar 2000)
AFORMED phenomenon As induced pulsus alternans progresses, a state in which alternating heart depolarisations fail to eject any blood, thus allowing longer diastolic filling; the subsequent beat is then able to produce a significant ejection; at high rates the cardiac minute volume and blood pressure may appear normal.
Origin: Alternating, failure of response, mechanical, to electrical depolarisation
(05 Mar 2000)
all-or-nothing phenomenon <physiology> Refers to the phenomenon where the strength of a nerve impulse is not dependent on the strength of the stimulus. Instead, there is a threshold level of stimulus strength that must be reached before the nerve will fire an impulse (at full capacity). Below the threshold, the nerve will not fire at all.
<cardiology> It also refers to the same phenomenon observed in the heart muscle, which will either contract fully or not at all.
<psychology> In studies of behaviour, it refers to the same phenomenon where a behavioural stimulus will either produce a complete response or no response at all. Also called all-or-nothing principle, all-or-none law, all-or-none responsiveness, etc.
(15 Nov 1997)
Anrep phenomenon Homeometric autoregulation of the heart whereby cardiac performance improves as the afterload (aortic pressure) is increased.
(05 Mar 2000)
aqueous influx phenomenon The filling of the aqueous vein, which normally carries blood and aqueous, with aqueous, when the junction of the aqueous vein and the recipient vein is partially occluded.
Synonym: Ascher's aqueous influx phenomenon.
(05 Mar 2000)
Arias-Stella phenomenon Focal, unusual, decidual changes in endometrial epithelium, consisting of intraluminal budding, and nuclear enlargement and hyperchromatism with cytoplasmic swelling and vacuolation; may be associated with ectopic or uterine pregnancy.
Synonym: Arias-Stella effect, Arias-Stella reaction.
(05 Mar 2000)
arm phenomenon In tetany, spasm both of the extensor muscles of the knee and of the calf muscles when the extended leg is flexed at the hip.
Synonym: leg phenomenon, Pool-Schlesinger sign, Schlesinger's sign.
In tetany, contraction of the arm muscles following the stretching of the brachial plexus by elevation of the arm above the head with the forearm extended, resembles the contraction resulting from stimulation of the ulnar nerve.
Synonym: arm phenomenon.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phenomenon
    »ç°Ç; Çö»ó
  • Raynaud's phenomenon
    ·¹À̳ë Çö»ó(¼ÕÀÇ ¼Òµ¿¸Æ ¼öÃà¿¡ ÀÇÇÑ ÀϽÃÀû Ç÷¾× ºÎÁ·À¸·Î ¼Õ°¡¶ô.¼ÕÀÇ ÀϺΰ¡ â¹éÇØ Áö´Â Çö»ó)
  • dellinger phenomenon
    µ¨¸°Àú Çö»ó 9
  • phenomenon
    Çö»ó;°æÀÌ;Áø±âÇÑ »ç¹°
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á